Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN)

CUSIP: G1281K122

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 5 signals
Share change
+140,169
SEC-reported price per share
$2.01
Indexed holders
3
Value change
+$280,847
Number of buys
3
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
3,320,313

Security key

G1281K122

Report period

Q4 2024

Indexed institutions

3

Top holders

2

Ownership snapshot

Top reported holders of SLXN - Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Wildcat Capital Managemen...
Disclosed value leader
Wildcat Capital Managemen...
Comparable rows
0/15
Latest evidence
30 Sep 2024
13F 3/4/5 Highest disclosed value: $535,947 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Wildcat Capital Management, LLC has the largest disclosed position value at $535.9K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Wildcat Capital Management, LLC's linked filing trail.
Disclosed position value Top 5
Wildcat Capital Management, LLC $535.9K
HRT FINANCIAL LP $47K
Polar Asset Management Partners Inc. $23.6K
LINDEN ADVISORS LP $17.1K
Virtu Financial LLC $14K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Wildcat Capital Management, LLC
13F 3/4/5
Company · 10%+ Owner
—
denominator unverified
$535,947
1,020,852 shares
— 30 Sep 2024
HRT FINANCIAL LP
13F
Company
13F
—
denominator unverified
$47,000
89,970 shares
— 30 Sep 2024
Polar Asset Management Partners Inc.
13F
Company
13F
—
denominator unverified
$23,568
743,475 shares
— 30 Sep 2024
LINDEN ADVISORS LP
13F
Company
13F
—
denominator unverified
$17,145
337,500 shares
— 30 Sep 2024
Virtu Financial LLC
13F
Company
13F
—
denominator unverified
$14,000
26,661 shares
— 30 Sep 2024
ARISTEIA CAPITAL, L.L.C.
13F
Company
13F
—
denominator unverified
$12,290
242,174 shares
— 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
3
Shares
140,169
Indexed holders
3
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2024 vs Q2 2025 Across Filers

Q2 2025 indexed holders
6
Q4 2024 indexed holders
3
Indexed holder difference
-3
Investor Q2 2025 Shares Q4 2024 Shares Share Diff Share Chg % Q2 2025 value Q4 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .